Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris Morehouse

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Muscle & Nerve|August 27, 2010
Permissive environment for B-cell maturation in myositis muscle in the absence of B-cell folliclesMohammad Salajegheh, Jack L Pinkus, Anthony A Amato, et al.
Clinical Immunology (Orlando, Fla.)|March 30, 2010
Human plasmacytoid dendritic cell accumulation amplifies their type 1 interferon productionAnne P Liao, Mohammad Salajegheh, Chris Morehouse, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 27, 2016
Type I IFNs Regulate Inflammation, Vasculopathy, and Fibrosis in Chronic Cutaneous Graft-versus-Host DiseaseTracy A Delaney, Chris Morehouse, P Zachary Brohawn, et al.
Transgenic Research|August 19, 2017
Generation of a functional humanized Delta-like ligand 4 transgenic mouse modelJohn Wiseman, Pernilla Gregersson, Johan Johansson, et al.
Vaccine|February 16, 2010
A whole genome transcriptional analysis of the early immune response induced by live attenuated and inactivated influenza vaccines in young childrenWei Zhu, Brandon W Higgs, Chris Morehouse, et al.
Stem Cells Translational Medicine|January 4, 2013
EZH2 is required for breast and pancreatic cancer stem cell maintenance and can be used as a functional cancer stem cell reporterLilian E van Vlerken, Christine M Kiefer, Chris Morehouse, et al.
Plos One|July 24, 2008
Type I interferon: potential therapeutic target for psoriasis?Yihong Yao, Laura Richman, Chris Morehouse, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 29, 2015
Type I Interferon Inhibition of MicroRNA-146a Maturation Through Up-Regulation of Monocyte Chemotactic Protein-Induced Protein 1 in Systemic Lupus ErythematosusBo Qu, Jianchang Cao, Feifei Zhang, et al.
Human Genomics and Proteomics : HGP|October 16, 2010
Development of Potential Pharmacodynamic and Diagnostic Markers for Anti-IFN-α Monoclonal Antibody Trials in Systemic Lupus ErythematosusYihong Yao, Brandon W Higgs, Chris Morehouse, et al.
BMC Cancer|February 28, 2014
Increased IR-A/IR-B ratio in non-small cell lung cancers associates with lower epithelial-mesenchymal transition signature and longer survival in squamous cell lung carcinomaLiyan Jiang, Wei Zhu, Katie Streicher, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Muscle & Nerve|August 27, 2010
Permissive environment for B-cell maturation in myositis muscle in the absence of B-cell folliclesMohammad Salajegheh, Jack L Pinkus, Anthony A Amato, et al.
Clinical Immunology (Orlando, Fla.)|March 30, 2010
Human plasmacytoid dendritic cell accumulation amplifies their type 1 interferon productionAnne P Liao, Mohammad Salajegheh, Chris Morehouse, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 27, 2016
Type I IFNs Regulate Inflammation, Vasculopathy, and Fibrosis in Chronic Cutaneous Graft-versus-Host DiseaseTracy A Delaney, Chris Morehouse, P Zachary Brohawn, et al.
Transgenic Research|August 19, 2017
Generation of a functional humanized Delta-like ligand 4 transgenic mouse modelJohn Wiseman, Pernilla Gregersson, Johan Johansson, et al.
Vaccine|February 16, 2010
A whole genome transcriptional analysis of the early immune response induced by live attenuated and inactivated influenza vaccines in young childrenWei Zhu, Brandon W Higgs, Chris Morehouse, et al.
Stem Cells Translational Medicine|January 4, 2013
EZH2 is required for breast and pancreatic cancer stem cell maintenance and can be used as a functional cancer stem cell reporterLilian E van Vlerken, Christine M Kiefer, Chris Morehouse, et al.
Plos One|July 24, 2008
Type I interferon: potential therapeutic target for psoriasis?Yihong Yao, Laura Richman, Chris Morehouse, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 29, 2015
Type I Interferon Inhibition of MicroRNA-146a Maturation Through Up-Regulation of Monocyte Chemotactic Protein-Induced Protein 1 in Systemic Lupus ErythematosusBo Qu, Jianchang Cao, Feifei Zhang, et al.
Human Genomics and Proteomics : HGP|October 16, 2010
Development of Potential Pharmacodynamic and Diagnostic Markers for Anti-IFN-α Monoclonal Antibody Trials in Systemic Lupus ErythematosusYihong Yao, Brandon W Higgs, Chris Morehouse, et al.
BMC Cancer|February 28, 2014
Increased IR-A/IR-B ratio in non-small cell lung cancers associates with lower epithelial-mesenchymal transition signature and longer survival in squamous cell lung carcinomaLiyan Jiang, Wei Zhu, Katie Streicher, et al.
Pageof 3